Agastiya Biotech
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
41743 Enterprise Cir N Ste 201, Temecula...Website
www.agastiyabiotech.comRevenue
<$5 MillionIndustry
About Agastiya Biotech
Agastiya Biotech is a pioneering oncology company focused on developing innovative cancer treatments through systems biology, immunotherapy, and quantum biophysics. Their lead product, AB001, is a first-in-class, orally available therapeutic designed to target various KRAS mutations and enhance cancer care across multiple indications. The company is also engaged in developing anti-viral therapeutics and novel formulations for cancer drug development, emphasizing tumor-agnostic efficacy and high tolerability. Agastiya Biotech aims to transform cancer treatment with its unique approach and advanced therapeutic solutions.Explore more
Agastiya Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Agastiya Biotech
Compare insights from companies similar to Agastiya Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Agastiya Biotech Tech Stack
A closer look at the technologies used by Agastiya Biotech
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Agastiya Biotech
Sign Up For FreeTo access detailed company insights
Agastiya Biotech is a pioneering oncology company focused on developing innovative cancer treatments through systems biology, immunotherapy, and quantum biophysics. Their lead product, AB001, is a first-in-class, orally available therapeutic designed to target various KRAS mutations and enhance cancer care across multiple indications. The company i... Read More
